Esposito Pamela
SEC Form 4 insider trading activity
Esposito Pamela has filed 5 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Esposito Pamela is listed as Director at Kymera Therapeutics, Inc. Inside the rolling window, Esposito Pamela reported no open-market purchases and 4 open-market sales totaling $3.1M in KYMR. The largest disclosed transaction in the window is a sale of 27,563 KYMR shares on Dec 17, 2025, worth $2.3M.
Companies traded
Other insiders at KYMR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Esposito Pamela made?
Esposito Pamela has filed 5 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.
Which companies does Esposito Pamela trade?
Esposito Pamela has filed SEC Form 4 disclosures for 1 company, including KYMR.
When was Esposito Pamela's most recent SEC Form 4 filing?
Esposito Pamela's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Esposito Pamela's total buy and sell value in the current window?
Inside the rolling retention window, Esposito Pamela bought $0 and sold $3.1M based on SEC Form 4 filings.
What was Esposito Pamela's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,563 KYMR shares on 2025-12-17, worth $2.3M, per SEC Form 4 filings.